[
  {
    "ts": "2026-02-15T11:53:40+00:00",
    "headline": "ResMed Inc. (RMD) Gains Analyst Confidence as Price Targets Rise on Strong Earnings",
    "summary": "ResMed Inc. (NYSE:RMD) is one of the best medical technology stocks to invest in. On January 30, KeyBanc Capital Markets lifted its price target on ResMed Inc. (NYSE:RMD) to $302 from $299 and maintained an Overweight rating. KeyBanc described ResMed’s second-quarter fiscal 2026 results as largely positive and supportive of its overall investment thesis for […]",
    "url": "https://finance.yahoo.com/news/resmed-inc-rmd-gains-analyst-115340197.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "0bc30516-84d3-32ab-901f-f63b0b33edea",
      "content": {
        "id": "0bc30516-84d3-32ab-901f-f63b0b33edea",
        "contentType": "STORY",
        "title": "ResMed Inc. (RMD) Gains Analyst Confidence as Price Targets Rise on Strong Earnings",
        "description": "",
        "summary": "ResMed Inc. (NYSE:RMD) is one of the best medical technology stocks to invest in. On January 30, KeyBanc Capital Markets lifted its price target on ResMed Inc. (NYSE:RMD) to $302 from $299 and maintained an Overweight rating. KeyBanc described ResMed’s second-quarter fiscal 2026 results as largely positive and supportive of its overall investment thesis for […]",
        "pubDate": "2026-02-15T11:53:40Z",
        "displayTime": "2026-02-15T11:53:40Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/21210cb1df0d0b2d2199188090fbb6c6",
          "originalWidth": 217,
          "originalHeight": 148,
          "caption": "ResMed Inc. (RMD) Gains Analyst Confidence as Price Targets Rise on Strong Earnings",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vAShHPtiDmDlbyUtZB6djQ--~B/aD0xNDg7dz0yMTc7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/21210cb1df0d0b2d2199188090fbb6c6.cf.webp",
              "width": 217,
              "height": 148,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RzBVDR50pA5SOjvkUUDYLw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/21210cb1df0d0b2d2199188090fbb6c6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/resmed-inc-rmd-gains-analyst-115340197.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/resmed-inc-rmd-gains-analyst-115340197.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RMD"
            },
            {
              "symbol": "RSMDF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]